Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Applied Genomics, |
RCV001268627 | SCV001447693 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001268627 | SCV004300001 | pathogenic | not provided | 2024-12-19 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 38 of the NDP protein (p.Arg38Cys). This variant is present in population databases (no rsID available, gnomAD 0.001%). This missense change has been observed in individual(s) with exudative vitreoretinopathy (FEVR) and/or Norrie disease (PMID: 14635119, 21960066, 30074570, 30452590; internal data). This variant is also known as C520T. ClinVar contains an entry for this variant (Variation ID: 987301). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on NDP protein function. For these reasons, this variant has been classified as Pathogenic. |
Genome Diagnostics Laboratory, |
RCV001268627 | SCV001806938 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001268627 | SCV001959420 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |